AAVantgarde names Rasmus Holm-Jorgensen CFO
28 Apr 2025 //
GLOBENEWSWIRE
AAVantgarde, TIGEM Publish Research in Science Advances
31 Mar 2025 //
GLOBENEWSWIRE
AAVantgarde To Present LUCE-1, Stargardt Data At ARVO 2025
10 Mar 2025 //
GLOBENEWSWIRE
AAVantgarde To Present LUCE-1 Study At FLORetina 2024 Meeting
02 Dec 2024 //
GLOBENEWSWIRE
AAVantgarde Announces 3 Oral Presentations At ESGCT 2024 Meeting
08 Oct 2024 //
GLOBENEWSWIRE
AAVantgarde Doses First Patient In LUCE-1 Study For Retinitis Pigmentosa
16 Sep 2024 //
GLOBENEWSWIRE
AAVantgarde appoints Dr. Jayashree Sahni as Chief Medical Officer
09 Sep 2024 //
GLOBENEWSWIRE
Charles River to Perform Plasmid Manufacturing for AAVantgarde
08 Jul 2024 //
BUSINESSWIRE
AAVantgarde`s Innovative Usher 1B Clinical Study Design
03 May 2024 //
GLOBENEWSWIRE
AAVantgarde NHP Stargardt Data at ARVO 2024
24 Apr 2024 //
GLOBENEWSWIRE
AAVantgarde Shows Positive Preclinical Stargardt Disease Data at ASGCT
23 Apr 2024 //
GLOBENEWSWIRE
AAVantgarde Closes 61 Million Series A Financing
06 Jun 2023 //
GLOBENEWSWIRE